Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Operating Cash Flow
Cash generated by the company's core business operations during the period.
Vivani Medical, Inc.NASDAQ: VANI
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow grows in line with its trailing trend
Q1 FY2026 operating cash flow of $6.2M (cash outflow) rose 20.0% year over year, ahead of the +18.3% change in trailing-twelve-month operating cash flow. Sequentially, it fell 7.8% from the prior quarter. Over 3 fiscal years it compounded at +9.0% a year.
Context
- Operating cash flow grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +20.0% holds above the trailing-twelve-month pace of +18.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (24.32M) USD
- Year-over-year change
- -17.0%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (24.32M) | -17.0% |
| FY2024 | 2024-12-31 | (20.79M) | +12.3% |
| FY2023 | 2023-12-31 | (23.7M) | -26.1% |
| FY2022 | 2022-12-31 | (18.79M) | -71.6% |
| FY2021 | 2021-12-31 | (10.95M) | — |
Operating Cash Flow vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +18.3% is the 3rd highest of 8, against a peer median of -14.5%.
- Over three fiscal years its annual growth of +9.0% compares with a peer median of -9.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
IMAImageneBio Inc | LTM Mar 2026 | $52.08M USD | +36.1% | -13.6% | — |
| LTM Mar 2026 | $30.96M USD | -19.3% | +17.8% | 42.8% | |
| LTM Mar 2026 | $27.71M USD | -22.0% | -27.2% | 180.7% | |
| LTM Mar 2026 | $25.35M USD | +18.3% | +9.0% | — | |
| LTM Mar 2026 | CA$24.24M CAD | -4.2% | -4.3% | — | |
| LTM Mar 2026 | $15.23M USD | +64.0% | +4.1% | 14500.0% | |
| LTM Mar 2026 | $8.94M USD | -14.5% | -31.7% | — | |
| LTM Mar 2026 | $7.59M USD | -35.8% | -9.7% | 7.2% | |
| Peer median (excluding VANI) | — | -14.5% | -9.7% | 111.8% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Depreciation & Amortization | 345K | 381K | 357K | 400K | 424K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.67M | 1.3M | 1.86M | 1.61M | 1.48M |
| Change in Working Capital | 436K | 338K | (1.29M) | 354K | 229K |
| Accounts Receivables | 0 | 0 | 0 | 0 | (401K) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 13K | (1.94M) | (602K) | 248K | (222K) |
| Other Working Capital | 423K | 2.28M | (691K) | 106K | 852K |
| Other Non-Cash Items | (627K) | (6.91M) | 1.03M | 336K | 152K |
| Operating Cash Flow | (10.95M) | (18.79M) | (23.7M) | (20.79M) | (24.32M) |
| Capital Expenditures | (572K) | (338K) | (887K) | (556K) | (1.17M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (572K) | (338K) | (887K) | (556K) | (1.17M) |
| Debt Repayment | 0 | 8M | 0 | 19.05M | 11K |
| Common Stock Issued | 11.62M | 16K | 133K | 18.82M | 23.29M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (28K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 55.37M | 0 | (18.82M) | 0 |
| Financing Cash Flow | 11.62M | 63.39M | 133K | 19.05M | 23.27M |
| Effect of Forex Changes | (1.1M) | (1K) | 3K | (14K) | 99K |
| Net Change in Cash | 97K | 44.26M | (24.45M) | (2.3M) | (2.12M) |
| Free Cash Flow | (11.52M) | (19.13M) | (24.59M) | (21.34M) | (25.49M) |
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.